CD44 specific target for selective elimination of human leukemia stem cells

References

[1] Wang J.C., Dick J.E. Cancer stem cells: lessons from leukemia. Trends Cell Biol. 2005; 15: 494-501.

[2] Hope K., Jin .L, Dick J.E. Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nat. Immunol. 2004; 5: 738-43.

[3] Bonnet D., Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 1997; 3: 730Œ7.

[4] Clarke M.F., Dick J.E., Dirks P.B. et al. Cancer Stem Cells Πperspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res. 2006; 66: 9339-44.

[5] Tallman M.S. New stratefies for the treatment of acute myeloid leukemia including anbtibodies and other novel agents. Hem. Am. Soc. Hematol. Educ. Program 2005; 143-50.

[6] Krause D.S., Lazarides K., von Andrian U.H. et al. Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells. Nat. Med. 2006; 12(10): 1175-80.

[7] Ponta H., Sherman L., Herrlich P.A. CD44: from adhesion molecules to signaling regulators. Nat. Rev. Mol. Cell Biol. 2003; 4: 33-45.

[8] Bendall L.J., Bradstock K.F., Gottlieb D.J. Expression of CD44 variant exons in acute myeloid leukemia is more common and more complex than that observed in normal blood, bone marrow or CD34+ cells. Leukemia 2000; 14: 1239-46.

[9] Al-Hajj M., Wicha M., Morrison S.J. et al. Prospective indentification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 2003; 100: 3983-8.

[10] Yilmaz O.H., Valdez R., Theisen B.K. et al. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 2006; 441(7092): 475-82.

RIGHTS & PERMISSIONS

Eco-Vector